15 years ago, Future in Focus published the linked Pandemic Forecast report which now proves critically relevant.
Our client is currently developing a revolutionary new transdermal drug delivery system that leverages the benefits of ultrasound.
Our client is identifying pharmaceuticals for in-licensing, supply, and tech transfer with regional exclusivity in Saudi Arabia.
First in class, disease-modifying, once a year infusion for osteoarthritis. Company seeking investment
Our client is a multinational pharmaceutical company with over 25 locations worldwide. They have a large product portfolio that currently includes over 30 products covering a broad array of indications.